Picture of Intocell logo

287840 Intocell Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Annual cashflow statement for Intocell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M
Source:PROSPECTUSPROSPECTUSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinal
Net Income/Starting Line-16,775-9,913-10,603
Depreciation
Amortisation
Non-Cash Items-57.2280576
Unusual Items
Other Non-Cash Items
Changes in Working Capital-7701,917640
Change in Accounts Receivable
Change in Other Assets
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-16,774-7,046-8,626
Capital Expenditures-1,072-1,237-1,304
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items9,9224,927-12,672
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities8,8503,690-13,975
Financing Cash Flow Items1500
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities10,0834,35627,618
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,1751,0125,016